title: Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review.
authors.affiliation: Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
authors.forename: Amy T
authors.initials: AT
authors.lastname: Wang
authors.forename: Christopher P
authors.initials: CP
authors.lastname: McCoy
authors.forename: Mohammad Hassan
authors.initials: MH
authors.lastname: Murad
authors.forename: Victor M
authors.initials: VM
authors.lastname: Montori
mesh_terms: D016265:Conflict of Interest; D003430:Cross-Sectional Studies; D003920:Diabetes Mellitus / Q000188:drug therapy*; D030881:Disclosure; D004345:Drug Industry / Q000191:economics* / Q000941:ethics; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D009203:Myocardial Infarction / Q000139:chemically induced*; D012307:Risk Factors; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone